16 research outputs found
DNA Measurements in Lymphomatoid Papulosis: Evidence for this New Entity**From the Laboratory for Special Histochemistry, Veterans Administration Hospital, Allen Park, Michigan 48101, and the Departments of Dermatology and Pathology Wayne State University School of Medicine and Detroit General Hospital, Detroit, Michigan.
Potential Clinical Applications of Matrix Metalloproteinase Inhibitors and their Future Prospects
Treatment with BB-94, a broad spectrum inhibitor of zinc-dependent metalloproteinases, causes deviation of the cytokine profile towards Type-2 in experimental pulmonary tuberculosis in Balb/c mice
Targeted therapies in small cell lung cancer: A review
Small cell lung cancer (SCLC) is an aggressive form of lung cancer that is characterized by a rapid doubling time, early onset of dissemination and high sensitivity to chemotherapy. Despite the potential for cure in patients with limited disease with concurrent chemoradiation and an initial good response to chemotherapy in extensive disease, there is a high chance of disease relapse with an overall poor median survival for both stages. With increasing translational research and a better understanding of the molecular basis of cancer, a number of molecular targets have been identified in various preclinical studies. This review summarizes potentially viable targets and new agents that have been developed and employed in recent, ongoing and future clinical trials to attempt to improve clinical outcomes in this disease